# Case Report: Recurrent intraocular pressure elevation during hemodialysis in a patient with pseudoexfoliation glaucoma

**Authors:** Joshua Eli Herman, Pushpinder Kanda, Ayub Akbari, Deeksha Kundapur, Soumya Podury, Januvi Jegatheswaran

PMC · DOI: 10.3389/fopht.2025.1658649 · 2025-09-29

## TL;DR

A patient with glaucoma experienced dangerous eye pressure spikes during dialysis, which were eventually controlled with surgery.

## Contribution

This case report highlights the need for surgical intervention in managing dialysis-related intraocular pressure spikes in glaucoma patients.

## Key findings

- The patient experienced IOP spikes up to mid 50s mmHg during hemodialysis.
- Medical management failed to control IOP, but Ahmed valve implantation stabilized it to 8–13 mmHg.
- Surgical intervention allowed return to standard dialysis and prevented further vision loss.

## Abstract

Intraocular pressure (IOP) elevation during dialysis has been observed in patients with glaucoma. This is thought to result from rapid shifts in plasma osmolality, leading to fluid movement into the anterior chamber, a phenomenon referred to as ocular dialysis disequilibrium. This case highlights a patient with advanced pseudoexfoliation glaucoma who developed recurrent, symptomatic IOP spikes during dialysis, posing management challenges.

Case report.

A 65-year-old male with advanced pseudoexfoliation glaucoma experienced recurrent left eye pain and vision loss during hemodialysis, with IOP spikes up to mid 50s (mmHg), requiring early dialysis termination. Medical management including topical drops, oral acetazolamide, and dialysis modifications failed to adequately control IOP. The patient later underwent Ahmed glaucoma valve implantation which stabilized IOP (8–13 mmHg), eliminated dialysis-related pain, and allowed return to standard dialysis sessions. At 6 months, visual acuity was 20/80 + 2 OS with IOP well controlled on topical therapy.

This case demonstrates that ocular dialysis disequilibrium can cause symptomatic IOP spikes in glaucoma patients and may be unresponsive to medical therapy alone. Surgical intervention may be necessary for long-term IOP control. Early recognition and interdisciplinary coordination between ophthalmology and nephrology is critical to prevent irreversible vision loss.

## Linked entities

- **Chemicals:** acetazolamide (PubChem CID 1986)
- **Diseases:** pseudoexfoliation glaucoma (MONDO:0008327)

## Full-text entities

- **Diseases:** vision loss (MESH:D014786), pseudoexfoliation glaucoma (MESH:D017889), left eye pain (MESH:D058447), IOP spikes (MESH:D031261), glaucoma (MESH:D005901), pain (MESH:D010146)
- **Chemicals:** acetazolamide (MESH:D000086)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12515614/full.md

---
Source: https://tomesphere.com/paper/PMC12515614